Leesburg, VA, May 9, 2019--Although arterial phase hyperenhancement (APHE) is a key feature of untreated or recurrent hepatocellular carcinoma (HCC), standard response assessment such as modified ...
HCC develops in patients with underlying chronic liver disease or cirrhosis via a multistep process of carcinogenesis, ranging from a DN to early HCC and, finally, to overt HCC. All these precursors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback